New research involving Agendia’s genomic tests MammaPrint®, BluePrint®, TargetPrint® and TheraPrint®, as well as its ColoPrint® Colon Cancer Genomic Profile, will be reported at the 2014 annual meeting of the American Society of Clinical Oncology (ASCO), May 30 – June 3 at McCormick Place in Chicago, Ill. The new data encompasses seven scientific posters and one oral presentation at the conference.
Help employers find you! Check out all the jobs and post your resume.
